|

Bevacizumab (or biosimilar) Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Avastin or mvasi

Pipeline

Phase 3: 1

Top Sponsors

  • The University of Hong Kong1
  • Genelux Corporation1

Indications

  • Cancer2
  • Ovarian Clear Cell Carcinoma1
  • Platinum-refractory Ovarian Cancer1
  • Recurrent Ovarian Carcinoma1
  • High-grade Serous Ovarian Cancer1

Other1 trial

Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
N/A

Mobile, Alabama1 trial

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

The University of South Alabama, Mitchell Cancer Institute

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.